GSK plc (LON:GSK)
1,963.50
-64.50 (-3.18%)
Apr 29, 2026, 8:44 AM GMT
GSK plc Revenue
In the year 2025, GSK plc had annual revenue of 32.67B GBP with 4.11% growth. GSK plc had revenue of 8.62B in the quarter ending December 31, 2025, with 6.17% growth.
Revenue
32.67B
Revenue Growth
+4.11%
P/S Ratio
2.48
Revenue / Employee
488.73K
Employees
66,841
Market Cap
80.96B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 32.67B | 1.29B | 4.11% |
| Dec 31, 2024 | 31.38B | 1.05B | 3.46% |
| Dec 31, 2023 | 30.33B | 1.00B | 3.42% |
| Dec 31, 2022 | 29.32B | 4.63B | 18.74% |
| Dec 31, 2021 | 24.70B | 342.00M | 1.40% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.64B |
| Haleon | 11.03B |
| Smith & Nephew | 4.58B |
| Convatec Group | 1.81B |
| Hikma Pharmaceuticals | 2.49B |
| HUTCHMED (China) | 407.54M |
| Genus | 672.00M |
| Oxford Nanopore Technologies | 223.90M |
GSK plc News
- 1 hour ago - GSK Earnings Boosted by Higher Specialty Medicine Sales - WSJ
- 1 hour ago - GSK Q1 Core Profit Rises; Affirms 2026 Guidance - Nasdaq
- 2 hours ago - GSK beats quarterly profit estimates on strength in respiratory, general medicines - Reuters
- 14 hours ago - GSK to Report Q1 Earnings with Strong Revenue Expectations - GuruFocus
- 19 hours ago - GSK Receives FDA Priority Review for Bepirovirsen in Chronic Hepatitis B Treatment - GuruFocus
- 20 hours ago - FDA Accepts Priority Review And Grants BT Designation For Bepirovirsen In Chronic Hepatitis B - Nasdaq
- 20 hours ago - GSK Receives Fast-Track Review for New Hepatitis B Treatment - GuruFocus
- 1 day ago - GSK Secures Breakthrough Therapy Designation for Efimosfermin - GuruFocus